Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0000899243-21-015558

Chief Executive Officer acquired 97 shares (code L)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Evans John M. Chief Executive Officer 2021-03-18 Other acquisition +33 1,040,365 D
Evans John M. Chief Executive Officer 2021-03-22 Other acquisition +32 1,040,397 D
Evans John M. Chief Executive Officer 2021-03-31 Other acquisition +32 1,040,429 D
Loading xslF345X03/doc4.xml…